Biotech Law 
Report: Bayer closing in on takeover of drug partner Onyx – The Business Journal
law Follow this company stock closed up 9 percent on rumors that longtime partner Bayer AG will soon close a deal to buy the South San Francisco biotech company. Bayer is zeroing in on a large acquisition, Reuters reported Wednesday. … Continue reading
Amgen To Shell Out $669M For Turkish Drugmaker – site.law360.com
Law360, New York (April 25, 2012, 3:08 PM ET) — California biotech giant Amgen Inc. is grabbing a majority stake in Mustafa Nevzat Pharmaceuticals, a family-owned Turkish maker of cancer medicines and a vital portal to the Middle Eastern country’s … Continue reading
Nutter’s Life Sciences Group Hosts Executive Forum on May 2nd – Market Wire
BOSTON, MA–(Marketwire – Apr 25, 2012) – The Life Sciences Group of the law firm of Nutter McClennen & Fish LLP will present The Business of Invention: Patenting for Biotechs on Wednesday, May 2 nd from 7:30 – 9:30 a.m., … Continue reading
Nutter’s Life Sciences Group Hosts Executive Forum on May 2nd – msnbc.com
BOSTON, MA — The Life Sciences Group of the law firm of Nutter McClennen & Fish LLP will present The Business of Invention: Patenting for Biotechs on Wednesday, May 2nd from 7:30 – 9:30 a.m., a forum for biotech executives and … Continue reading
EuroMedtech™ 2012 in Grenoble is Welcomed by Region’s BioCluster Members – TMCnet
Also attending are companies serving the industry, such as manufacturers, law firms, CROs and distributors … “ADEBAG’s role is the development and promotion of medtech, biotech, bio-industry and e-health innovative companies of Grenoble …
Passing of Genmab A/S’ Annual General Meeting – msnbc.com
About Genmab A/S Genmab is a publicly traded, international biotechnology company specializing in the creation … such statements in relation to actual results, unless required by law. Genmab(r); the Y-shaped Genmab logo(r); HuMax(r); HuMax-CD20(r …
Paul Hastings Advises Biotech on Purchase by AstraZeneca – Law.com
SAN FRANCISCO — A team of Paul Hastings lawyers in San Diego and Washington, D.C., represented Southern California biotech company Ardea Biosciences Inc. in its $1.26 billion sale to United Kingdom-based AstraZeneca. Data is unavailable for this article.
Immunovaccine Inc.: Biotech Investment Banker Leouzon to Join IMV Board – Market Wire
HALIFAX, NOVA SCOTIA–(Marketwire – April 24, 2012) – European biotech investment banker Stephanie Léouzon … This press release contains forward-looking information under applicable securities law. All information that addresses activities or …
Dyadic International To Release First Quarter 2012 Financial Results And Host Conference Call – Miami Herald
April 24, 2012 — /PRNewswire/ – Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company … Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.
Covington Advises AstraZeneca in $1.26 Billion Acquisition of Ardea Biosciences – Marketwatch
Ardea is a biotechnology company based in San Diego … Covington & Burling LLP, an international law firm, provides corporate, litigation, and regulatory expertise to enable clients to achieve their goals. Founded in 1919, the firm has more …
